Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02465099 · ClinicalTrials.gov registry record · Phase 4
Posterior Spinal Fusion With Two Energy Dissection Techniques
A Phase 4 study, sponsored by Ethicon Endo-Surgery.
- Terminated
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT02465099 is a Phase 4 study that was terminated before completion, run by Ethicon Endo-Surgery. The registered enrollment target is 64 participants.
The verdict
NCT02465099, a Phase 4 study, was terminated before completion, sponsored by Ethicon Endo-Surgery.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
The OSTEOVUE™ Spine Dissector is a new ultrasonic energy device, specifically designed for soft tissue removal from vertebral surfaces. The aim of the present study is to compare blood loss in multilevel PSF surgeries in patients with adolescent scoliosis (idiopathic or neuromuscular) done with ED or with UD. Blood loss will be estimated by major intraoperative surgical Stage (1 and 2) and postoperatively (until discharge). Additionally, the study will assess the possible influence of the device use in secondary perioperative outcomes.
Interventions
- DEVICE Ultrasonic Dissection (UD)
- DEVICE Electrocautery Dissection (ED)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2016-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02465099
The ClinicalTrials.gov registry entry for NCT02465099 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasonic Dissection (UD) is the first listed.
NCT02465099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02465099 about?
NCT02465099 is a clinical study titled "Posterior Spinal Fusion With Two Energy Dissection Techniques". The OSTEOVUE™ Spine Dissector is a new ultrasonic energy device, specifically designed for soft tissue removal from vertebral surfaces. The aim of the present study is to compare blood loss in multilevel PSF surgeries in patients with adolescent scoliosis (idiopathic or neuromuscular) done with ED o...
What is the current status of trial NCT02465099?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2015-06-01. Estimated completion is 2016-05-01.
What interventions are being tested in trial NCT02465099?
The interventions under investigation include: Ultrasonic Dissection (UD) (DEVICE), Electrocautery Dissection (ED) (DEVICE).
Who is sponsoring clinical trial NCT02465099?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.